Leading Indian agrochemical company manufacturing crop-protection formulations for 10M+ farmers pan-India.
Price
Market Cap
Sector
Commodities
Rank
| Line item | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves | 624 | 633 | 698 | 787 | 951 | 1.1k | 1.2k | 1.4k | 1.7k |
| Borrowings | 5 | 22 | 8 | 48 | 32 | 34 | 27 | 74 | 31 |
| Other Liabilities | 185 | 171 | 217 | 286 | 320 | 310 | 296 | 323 | 390 |
| Total Liabilities | 823 | 835 | 932 | 1.1k | 1.3k | 1.4k | 1.6k | 1.8k | 2.1k |
| AssetsFixed Assets | 131 | 117 | 117 | 167 | 159 | 165 | 338 | 504 | 467 |
| CWIP | 0 | 1 | 4 | 8 | 48 | 153 | 28 | 9 | 12 |
| Investments | 182 | 120 | 159 | 278 | 336 | 255 | 240 | 230 | 371 |
| Other Assets | 510 | 597 | 652 | 679 | 769 | 833 | 973 | 1.1k | 1.3k |
| Total Assets | 823 | 835 | 932 | 1.1k | 1.3k | 1.4k | 1.6k | 1.8k | 2.1k |
| Line item | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 138 | 13 | 162 | 231 | 104 | 136 | 134 | 263 |
| Cash from Investing | -111 | 63 | -44 | -127 | -43 | 3 | -81 | -143 |
| Cash from Financing | -20 | -87 | -93 | -129 | -61 | -137 | -57 | -120 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 131 | 9 | 152 | 219 | 46 | 36 | 46 | 74 |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (19.7×) and current (16.0×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 7.3% growth and a 16× exit, ₹1017 only delivers your return if you pay ₹616. The price is currently baking in 18% growth.
EPS grows 7.3%/yr for 5 years, then fades to 6% over 2, exits at 16×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 7.3% | 68.37 |
| FY28 | 7.3% | 73.36 |
| FY29 | 7.3% | 78.72 |
| FY30 | 7.3% | 84.46 |
| FY31 | 7.3% | 90.63 |
| FY32 | 6.7% ·fade | 96.66 |
| FY33 | 6.0% ·fade | 102.46 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.